P
Parvaneh Rahimi-Moghaddam
Researcher at Iran University of Medical Sciences
Publications - 33
Citations - 1527
Parvaneh Rahimi-Moghaddam is an academic researcher from Iran University of Medical Sciences. The author has contributed to research in topics: Insulin resistance & Pioglitazone. The author has an hindex of 13, co-authored 32 publications receiving 1382 citations. Previous affiliations of Parvaneh Rahimi-Moghaddam include University of Saskatchewan & Tehran University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Free-radical scavenging capacity and antioxidant activity of selected plant species from the Canadian prairies
TL;DR: In this article, a b-carotene-linoleic acid (linoleate) model system was used to evaluate the scavenging effect on the DPPH free radical and capacity to scavenge hydroxyl free radicals.
Journal ArticleDOI
The anti-cancer activity of noscapine: a review.
TL;DR: Noscapine is an isoqiunoline alkaloid found in opium latex that has great potential as novel anti-cancer agents and has been introduced as an anti-mitotic agent.
Journal ArticleDOI
Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: Relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes
TL;DR: The findings suggest that in carriers of the 12Ala variant, pioglitazone significantly reduced the risk of type 2 diabetes, and in diabetic patients with the Pro12Ala genotype, the therapeutic response to treatment was better than in patients withThe Pro12Pro genotypes, although the difference between groups did not reach statistical significance.
Journal ArticleDOI
In vitro selection and characterization of deoxyribonucleic acid aptamers for digoxin.
Zahra Kiani,Massoumeh Shafiei,Parvaneh Rahimi-Moghaddam,Ali Asghar Karkhane,Soltan Ahmed Ebrahimi +4 more
TL;DR: The finding indicated that D1 anti-digoxin aptamer can selectively bind to digoxin, and further studies might show its suitability for use in digoxin assays and as a therapeutic agent in life-threatening digoxin toxicity.
Journal Article
In vitro and in vivo activities of Peganum harmala extract against Leishmania major.
Parvaneh Rahimi-Moghaddam,Soltan Ahmad Ebrahimi,Hourmazd Ourmazdi,Monavvar Selseleh,Maryam Karjalian,Giti Haj-Hassani,Mohammad Hossein Alimohammadian,Massoud Mahmoudian,Massoumeh Shafiei +8 more
TL;DR: In vivo studies demonstrated a significant post-treatment decrease in the lesion size and parasite count in infected animals, compared to placebo and control groups and high performance liquid chromatography of the crude extract demonstrated the existence of harmaline and harmine as beta-carboline alkaloids.